Latest Insider Transactions at Genocea Biosciences, Inc. (GNCA)
This section provides a real-time view of insider transactions for Genocea Biosciences, Inc. (GNCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GENOCEA BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GENOCEA BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 10
2020
|
William D Clark President and CEO |
BUY
Open market or private purchase
|
Direct |
4,760
+50.0%
|
$9,520
$2.06 P/Share
|
|
Jul 24
2020
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,260,504
+21.41%
|
$2,521,008
$2.25 P/Share
|
|
Jun 24
2019
|
Glaxosmithkline PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,857,142
+35.56%
|
$5,571,426
$3.5 P/Share
|